Canopy Growth CGC
NASDAQ CGC
$1.04 +0.00 (+0.48%)
At close: Aug 20, 2026 · 1:59 PM UTC

Canopy Growth (CGC) Total Current Liabilities (2017 - 2026)

Canopy Growth (CGC) posted Total Current Liabilities of $115.5 million for Q1 2026, up 47.37% sequentially from $78.4 million in Q4 2025, and up 60.88% YoY from $71.8 million in Q1 2025.

Canopy Growth (CGC) Total Current Liabilities (2017 - 2026) Analysis & Trends

Canopy Growth has reported Total Current Liabilities for 10 years, with the latest figure at $115.5 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 60.88% year-over-year to $115.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.5 million (up 60.88% YoY) and the FY2026 annual result came in at $115.5 million, up 60.88% from the prior year.
  • Total Current Liabilities rose to $115.5 million in Q1 2026 per CGC's latest filing, from $78.4 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $594.6 million in Q1 2023 and troughed at $70.1 million in Q3 2025.
  • A 5-year average of $226.1 million and a median of $169.6 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities soared 253.28% in 2023, then slumped 71.08% in 2025.
  • Over 5 years, Total Current Liabilities stood at $500.3 million in 2022, then tumbled by 66.11% to $169.6 million in 2023, then tumbled by 44.92% to $93.4 million in 2024, then declined by 16.07% to $78.4 million in 2025, then surged by 47.37% to $115.5 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $115.5 million, $78.4 million, and $70.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -8.38 Bn
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn 15.65 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn 2.06 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 17.34 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 6.35 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 874.50 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 1.85 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 1.79 Bn
10 Canopy Growth 441.27 Mn 194.25 Mn 16.08 Mn 120.55 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 120.55 Mn
Mar 31, 2026 115.54 Mn
Dec 31, 2025 78.40 Mn
Sep 30, 2025 70.07 Mn
Jun 30, 2025 79.86 Mn
Mar 31, 2025 71.82 Mn
Dec 31, 2024 93.41 Mn
Sep 30, 2024 239.44 Mn
Jun 30, 2024 169.92 Mn
Mar 31, 2024 248.35 Mn
Dec 31, 2023 169.58 Mn
Sep 30, 2023 161.80 Mn
Jun 30, 2023 335.86 Mn
Mar 31, 2023 594.60 Mn
Dec 31, 2022 500.33 Mn
Sep 30, 2022 428.33 Mn
Jun 30, 2022 317.33 Mn
Mar 31, 2022 168.31 Mn
Dec 31, 2021 189.80 Mn
Sep 30, 2021 206.47 Mn